MX2018008085A - Vacuna marcadora contra pestivirus. - Google Patents
Vacuna marcadora contra pestivirus.Info
- Publication number
- MX2018008085A MX2018008085A MX2018008085A MX2018008085A MX2018008085A MX 2018008085 A MX2018008085 A MX 2018008085A MX 2018008085 A MX2018008085 A MX 2018008085A MX 2018008085 A MX2018008085 A MX 2018008085A MX 2018008085 A MX2018008085 A MX 2018008085A
- Authority
- MX
- Mexico
- Prior art keywords
- pestivirus
- marker vaccine
- provides
- pestivirus marker
- mutant pestivirus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24361—Methods of inactivation or attenuation
- C12N2770/24362—Methods of inactivation or attenuation by genetic engineering
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24371—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención proporciona un Pestivirus mutante que comprende un gen Erns quimérico, el cual proporciona al Pestivirus mutante con la capacidad para evadir la detección serológica, pero mantiene buenas propiedades de vacuna y replicación viral.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15203202 | 2015-12-30 | ||
PCT/EP2016/082537 WO2017114778A1 (en) | 2015-12-30 | 2016-12-23 | Pestivirus marker vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018008085A true MX2018008085A (es) | 2018-08-23 |
Family
ID=55085493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018008085A MX2018008085A (es) | 2015-12-30 | 2016-12-23 | Vacuna marcadora contra pestivirus. |
Country Status (11)
Country | Link |
---|---|
US (1) | US20190240311A1 (es) |
EP (1) | EP3397280A1 (es) |
JP (1) | JP2019506850A (es) |
CN (1) | CN108430504A (es) |
AR (1) | AR107261A1 (es) |
AU (1) | AU2016382839A1 (es) |
BR (1) | BR112018013400A2 (es) |
CA (1) | CA3006921A1 (es) |
MX (1) | MX2018008085A (es) |
RU (1) | RU2018127402A (es) |
WO (1) | WO2017114778A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102018110208A1 (de) * | 2018-04-27 | 2019-10-31 | Stiftung Tierärztliche Hochschule Hannover | Gentechnisch veränderte Pestiviren und deren Verwendung als Markerimpfstoff |
JP6976621B1 (ja) * | 2021-02-04 | 2021-12-08 | 株式会社Icst | 検査器具、検査キットおよび検査方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1174506A1 (en) * | 2000-06-28 | 2002-01-23 | Stichting Dienst Landbouwkundig Onderzoek | C-terminal Erns peptide and analogues thereof |
AU2009323784B2 (en) * | 2008-12-03 | 2013-08-15 | Zoetis Services Llc | Bovine viral diarrhea virus with a modified Erns protein |
AU2012298229B2 (en) * | 2011-08-24 | 2015-12-10 | Zoetis Services Llc | Improved vaccine diagnostics |
RU2015111179A (ru) * | 2012-08-29 | 2016-10-20 | Интервет Интернэшнл Б.В. | Маркерная вакцина |
-
2016
- 2016-12-23 CN CN201680077202.3A patent/CN108430504A/zh active Pending
- 2016-12-23 JP JP2018534137A patent/JP2019506850A/ja active Pending
- 2016-12-23 BR BR112018013400A patent/BR112018013400A2/pt not_active Application Discontinuation
- 2016-12-23 AU AU2016382839A patent/AU2016382839A1/en not_active Abandoned
- 2016-12-23 EP EP16826054.5A patent/EP3397280A1/en not_active Withdrawn
- 2016-12-23 MX MX2018008085A patent/MX2018008085A/es unknown
- 2016-12-23 CA CA3006921A patent/CA3006921A1/en not_active Abandoned
- 2016-12-23 US US16/066,218 patent/US20190240311A1/en not_active Abandoned
- 2016-12-23 RU RU2018127402A patent/RU2018127402A/ru not_active Application Discontinuation
- 2016-12-23 WO PCT/EP2016/082537 patent/WO2017114778A1/en active Application Filing
- 2016-12-29 AR ARP160104074A patent/AR107261A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
BR112018013400A2 (pt) | 2018-12-18 |
EP3397280A1 (en) | 2018-11-07 |
AU2016382839A1 (en) | 2018-06-21 |
RU2018127402A3 (es) | 2020-01-30 |
WO2017114778A1 (en) | 2017-07-06 |
US20190240311A1 (en) | 2019-08-08 |
AR107261A1 (es) | 2018-04-11 |
CA3006921A1 (en) | 2017-07-06 |
CN108430504A (zh) | 2018-08-21 |
RU2018127402A (ru) | 2020-01-30 |
JP2019506850A (ja) | 2019-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276679B (en) | Cells reject viruses and their uses | |
HK1257074A1 (zh) | 溶瘤病毒株 | |
EP3350855A4 (en) | CARBON BLACK FROM NATURAL GAS | |
EP3351617A4 (en) | NOVEL LACTOBACILLUS WITH VARIOUS FUNCTIONS AND USE THEREOF | |
EP3120225A4 (en) | Orthogonal signaling touch user, hand and object discrimination systems and methods | |
EP3092207A4 (en) | High aspect boron nitride, methods, and composition containing the same | |
MX2018002106A (es) | Vacunas terapeuticas contra el hpv18. | |
MY181175A (en) | Therapeutic hpv16 vaccines | |
EP3144728A4 (en) | Toner binder, and toner | |
EP3208101A4 (en) | Pen, and refill for pen | |
PT3397702T (pt) | Tinta piezorresistiva, métodos e utilizações da mesma | |
Sanyal | Culture and assay systems used for 3D cell culture | |
GB2532302B (en) | Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms. | |
EP3200878A4 (en) | Hiv vaccines comprising one or more population episensus antigens | |
AU2015315168A8 (en) | Targeted mutagenesis in spirulina | |
EP3228252A4 (en) | Catheter holder, and catheter set | |
EP3710018A4 (en) | ONCOLYTIC VIRUSES DECORATED BY A TARGETING FRACTION | |
EP3138908A4 (en) | Novel glycosyltransferase gene and use thereof | |
EP3425043A4 (en) | PERIODICALLY ARRANGED SPHÄROID OF UNIFORM SIZE AND USE THEREOF | |
MX2018008085A (es) | Vacuna marcadora contra pestivirus. | |
EP3216868A4 (en) | Virus vector, cell, and construct | |
EP3318320A4 (en) | GROUP OF GRAPHITES, CARBON PARTICLES CONTAINING SAID GROUP OF GRAPHITES | |
EP3212699A4 (en) | Suspension polymerization compositions, methods and use thereof | |
Ligeti | Weberns Melodik | |
EP3201382A4 (en) | Styrene-containing copolymer fibers, filter media, elements, and methods |